5-[[4-(4-but-2-enoxyphenyl)phenyl]methyl]-2-(2,3-difluorophenyl)imidazo[4,5-c]pyridine
C29H23F2N3O — CID 72524761
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-[[4-(4-but-2-enoxyphenyl)phenyl]methyl]-2-(2,3-difluorophenyl)imidazo[4,5-c]pyridine
5-[[4-(4-but-2-enoxyphenyl)phenyl]methyl]-2-(2,3-difluorophenyl)imidazo[4,5-c]pyridine (PubChem CID 72524761) has the molecular formula C29H23F2N3O and a molecular weight of 467.52 g/mol. Its IUPAC name is 5-[[4-(4-but-2-enoxyphenyl)phenyl]methyl]-2-(2,3-difluorophenyl)imidazo[4,5-c]pyridine.
Molecular Properties
| Compound Name | 5-[[4-(4-but-2-enoxyphenyl)phenyl]methyl]-2-(2,3-difluorophenyl)imidazo[4,5-c]pyridine |
|---|---|
| PubChem CID | 72524761 |
| Molecular Formula | C29H23F2N3O |
| Molecular Weight | 467.52 g/mol |
| Exact Mass | 467.18 |
| IUPAC Name | 5-[[4-(4-but-2-enoxyphenyl)phenyl]methyl]-2-(2,3-difluorophenyl)imidazo[4,5-c]pyridine |
| SMILES | CC=CCOc1ccc(-c2ccc(Cn3ccc4nc(-c5cccc(F)c5F)nc-4c3)cc2)cc1 |
| InChI | InChI=1S/C29H23F2N3O/c1-2-3-17-35-23-13-11-22(12-14-23)21-9-7-20(8-10-21)18-34-16-15-26-27(19-34)33-29(32-26)24-5-4-6-25(30)28(24)31/h2-16,19H,17-18H2,1H3 |
| InChIKey | JIMGGVCCBAJLIE-UHFFFAOYSA-N |
| XLogP | 7.00 |
| TPSA | 39.94 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 35 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 467.52 |
| LogP ≤ 5 | 7.00 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 4 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'isolated_alkene', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 72524761 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.